Exodus Point Capital Management, LP Biocryst Pharmaceuticals Inc Transaction History

Exodus Point Capital Management, LP

$11.4 Billion
Q2 2025

A detailed history of Exodus Point Capital Management, LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 210,840 shares of BCRX stock, worth $1.53 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

210,840

Previous 60,933 246.02%

Holding current value

$1.53 Million

Previous $457,000 313.35%

% of portfolio

0.02%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$6.41 - $11.19 $960,903 - $1.68 Million	149,907 Added 246.02%	210,840 $1.89 Million
Q1 2025 May 14, 2025	BUY	$7.06 - $9.39 $430,186 - $572,160	60,933 New	60,933 $457,000
Q1 2024 May 14, 2024	SELL	$4.89 - $7.65 $2.82 Million - $4.41 Million	-577,092 Reduced 76.94%	172,961 $879,000
Q3 2023 Nov 09, 2023	SELL	$6.71 - $7.92 $3.1 Million - $3.66 Million	-462,494 Reduced 38.14%	750,053 $5.31 Million
Q2 2023 Aug 10, 2023	SELL	$6.96 - $8.81 $63,572 - $80,470	-9,134 Reduced 0.75%	1,212,547 $8.54 Million
Q1 2023 May 11, 2023	BUY	$7.94 - $11.84 $9.53 Million - $14.2 Million	1,199,839 Added 5493.27%	1,221,681 $10.2 Million
Q4 2022 Feb 13, 2023	SELL	$10.5 - $14.2 $7.22 Million - $9.76 Million	-687,443 Reduced 96.92%	21,842 $251,000
Q3 2022 Nov 10, 2022	BUY	$10.79 - $14.81 $3,949 - $5,420	366 Added 0.05%	709,285 $8.94 Million
Q2 2022 Aug 19, 2022	BUY	$7.89 - $17.88 $5.59 Million - $12.7 Million	708,919 New	708,919 $7.5 Million
Q1 2022 May 13, 2022	SELL	$11.56 - $19.76 $1.4 Million - $2.39 Million	-120,827 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$11.18 - $15.46 $877,987 - $1.21 Million	78,532 Added 185.68%	120,827 $1.67 Million
Q3 2021 Nov 15, 2021	SELL	$14.21 - $17.65 $1.13 Million - $1.4 Million	-79,308 Reduced 65.22%	42,295 $608,000
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $1.16 Million - $2.1 Million	121,603 New	121,603 $1.92 Million
Q3 2020 Nov 16, 2020	SELL	$3.43 - $5.53 $123,373 - $198,908	-35,969 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.9 - $5.61 $68,341 - $201,786	35,969 New	35,969 $171,000

Others Institutions Holding BCRX

# of Institutions

315

Shares Held

201M

Call Options Held

930K

Put Options Held

553K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.35B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Biocryst Pharmaceuticals Inc Transaction History